536-38-9 | 2-Bromo-4'-chloroacetophenone

Packsize	Purity	Availability	Price	Discounted Price
5g	97%	in stock	$14.00	$10.00
10g	97%	in stock	$23.00	$17.00
25g	98%(GC)	in stock	$34.00	$24.00
100g	98%	in stock	$106.00	$75.00
500g	98%	in stock	$473.00	$331.00

Description

• Catalog Number: AB67090
• Chemical Name: 2-Bromo-4'-chloroacetophenone
• CAS Number: 536-38-9
• Molecular Formula: C8H6BrClO
• Molecular Weight: 233.4896
• MDL Number: MFCD00000625
• SMILES: BrCC(=O)c1ccc(cc1)Cl
• NSC Number: 8452

Computed Properties

• Complexity: 141
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 1
• Rotatable Bond Count: 2
• XLogP3: 3.1

Literature

• 1-(4-Chloro-phen-yl)-2-[4-hy-droxy-3-(3-meth-oxy-benzo-yl)-1,1-dioxo-2H-1λ(6),2-benzothia-zin-2-yl]ethanone.

  Acta crystallographica. Section E, Structure reports online 20120401

• (2-Anilino-4-methyl-thia-zol-5-yl)(4-chloro-phen-yl)methanone.

  Acta crystallographica. Section E, Structure reports online 20120101

• 2-(4-Chloro-phen-yl)-2-oxoethyl 3,4-dimeth-oxy-benzoate.

  Acta crystallographica. Section E, Structure reports online 20111201

• 2-(4-Chloro-anilino)-1-(4-chloro-phen-yl)ethanone.

  Acta crystallographica. Section E, Structure reports online 20111201

• 2-(4-Chloro-phen-yl)-2-oxoethyl 4-methyl-benzoate.

  Acta crystallographica. Section E, Structure reports online 20111101

• 2-(4-Chloro-phen-yl)-2-oxoethyl 4-hy-droxy-benzoate.

  Acta crystallographica. Section E, Structure reports online 20111001

• 2-(4-Chloro-phen-yl)-2-oxoethyl 3-(trifluoro-meth-yl)benzoate.

  Acta crystallographica. Section E, Structure reports online 20110701

• 2-(4-Chloro-phen-yl)-2-oxoethyl 2,4-di-fluoro-benzoate.

  Acta crystallographica. Section E, Structure reports online 20110701

• 2-(4-Chloro-phen-yl)-2-oxoethyl 2-meth-oxy-benzoate.

  Acta crystallographica. Section E, Structure reports online 20110701

• 2-(4-Chloro-phen-yl)-2-oxoethyl benzoate.

  Acta crystallographica. Section E, Structure reports online 20110701

• Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.

  Journal of medicinal chemistry 20110623

• FT-IR and FT-Raman spectral investigation, computed IR intensity and Raman activity analysis and frequency estimation analysis on 4-chloro-2-bromoacetophenone using HF and DFT calculations.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110201

• 6-(4-Chloro-phen-yl)-2-isobutyl-imidazo[2,1-b][1,3,4]thia-diazole.

  Acta crystallographica. Section E, Structure reports online 20110101

• 1-(4-Chloro-phen-yl)-2-[(3-phenyl-isoquinolin-1-yl)sulfan-yl]ethanone.

  Acta crystallographica. Section E, Structure reports online 20090201

• Precolumn derivatization of cysteine residues for quantitative analysis of five major cytochrome P450 isoenzymes by liquid chromatography/tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20070101

• Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching.

  Journal of medicinal chemistry 20031023